Infectious Disease Rapid Diagnostic Testing Market Key Players, End User, Demand and Analysis Growth Trends by 2027

Market Size – USD 1,480.0 Million in 2019, Market Growth – CAGR of 12.2%, Market trends – Growth in funding for the testing product.

The rising incidence of infectious diseases and shift in focus from centralized laboratories to decentralized (POC) point-of-care testing is driving the market demand.

 The global Infectious Disease Rapid Diagnostic Testing Market is forecasted to be worth USD 3.56 Billion by 2027, according to a current analysis by Emergen Research. The rising cases of infectious disease all over the globe and the need for the immediate diagnosis will propel market growth. The evolving pathogens and rise in the occurrence of hospital-acquired infections (HAIs) are creating a need for a quick diagnosis of the diseases to stop the spread. Governments all over the world are investing in rapid diagnostic testing kits to increase their rate of testing and prevent any sort of epidemic.

Download Sample PDF Copy of this Report At:

The advancement in technology has also encouraged the Infectious Disease Rapid Diagnostic Testing market growth. Investment in research and development has helped in the development of effective diagnostic testing kits, which have helped in the advancement in the market product. However, the lack of proper reimbursement rates may result in lower access for patients to testing, which hinders market growth.

The report on the Global Infectious Disease Rapid Diagnostic Testing Market is an investigative study on the key features of the business landscape along with an analysis of the growth opportunities, challenges, threats, drivers and restraints, and limitations of the market. The report also offers insights into the segments, sub-segments, and regions exhibiting promising growth.

Key participants include Abbott Laboratories, Danaher Corporation, BGI Group, DiaSorin S.p.A, F. Hoffmann-La Roche Ltd., Luminex Corporation, bioMérieux S.A., Hologic, Inc., Thermo Fisher Scientific Inc., and Becton, Dickinson, and Company, among others.

For the purpose of this report, Emergen Research has segmented into the global Infectious Disease Rapid Diagnostic Testing market on the basis of product, technology, disease, end-user, and region:

  • Product Outlook (Revenue, USD Billion; 2017-2027)
    • Platforms
    • Assays
  • Technology Outlook (Revenue, USD Billion; 2017-2027)
    • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • Enzyme Immunoassay (EIA)
    • Real-Time PCR (q-PCR)
    • Lateral Flow Immunoassay (LFIA)
    • Others
  • Disease Outlook (Revenue, USD Billion; 2017-2027)
    • Bacterial Infection
      1. CT/NG
      2. HAIs
      3. Tuberculosis
      4. Others
    • Viral Infection
      1. Hepatitis
      2. Influenza Virus
      3. HPV
      4. HIV-AIDS
      5. Others
    • Others Infections
  • End-User Outlook (Revenue, USD Billion; 2017-2027)
    • Clinics
    • Hospital
    • Diagnostic Center
    • Others

Regional Analysis Covers:

  • North America (U.S., Canada)
  • Europe (U.K., Italy, Germany, France, Rest of EU)
  • Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
  • Latin America (Chile, Brazil, Argentina, Rest of Latin America)
  • Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

To get leading market solutions, visit the link below:

Radical Features of the Infectious Disease Rapid Diagnostic Testing Market Report:

  • The report encompasses Infectious Disease Rapid Diagnostic Testing market overview along with market share, demand and supply ratio, production and consumption patterns, supply chain analysis, and other ley elements
  • An in-depth analysis of the different approaches and procedures undertaken by the key players to conduct business efficiently
  • Offers insights into production and manufacturing value, products and services offered in the market, and fruitful information about investment strategies
  • Supply chain analysis along with technological advancements offered in the report
  • The report covers extensive analysis of the trends, drivers, restraints, limitations, threats, and growth opportunities in the Infectious Disease Rapid Diagnostic Testing industry

Table of Content

Chapter 1. Methodology & Sources

    1.1. Market Definition

    1.2. Research Scope

    1.3. Methodology

    1.4. Research Sources

          1.4.1. Primary

          1.4.2. Secondary

          1.4.3. Paid Sources

    1.5. Market Estimation Technique

Chapter 2. Executive Summary

    2.1. Summary Snapshot, 2019-2027

Chapter 3. Key Insights

Chapter 4. Infectious Disease Rapid Diagnostic Testing Market Segmentation & Impact Analysis

    4.1. Infectious Disease Rapid Diagnostic Testing Market Material Segmentation Analysis

    4.2. Industrial Outlook

          4.2.1. Market indicators analysis

          4.2.2. Market drivers analysis

           Increasing prevalence of infectious diseases

           Growth in funding for research on infectious disease diagnostics

          4.2.3. Market restraints analysis

           Inadequate reimbursements

    4.3. Technological Insights

    4.4. Regulatory Framework

    4.5. Porter’s Five Forces Analysis

    4.6. Competitive Metric Space Analysis

    4.7. Price trend Analysis

    4.8. Covid-19 Impact Analysis

Chapter 5. Infectious Disease Rapid Diagnostic Testing Market By Product Insights & Trends Revenue (USD Million)

    5.1. Product Dynamics & Market Share, 2019 & 2027

          5.1.1. Platforms

          5.1.2. Assays

Chapter 6. Infectious Disease Rapid Diagnostic Testing Market By Technology Insights & Trends Revenue (USD Million)

    6.1. Technology Dynamics & Market Share, 2019 & 2027

          6.1.1. Isothermal Nucleic Acid Amplification Technology (INAAT)

          6.1.2. Enzyme Immunoassay (EIA)

          6.1.3. Real-Time PCR (q-PCR)

          6.1.4. Lateral Flow Immunoassay (LFIA)

          6.1.5. Others

Chapter 7. Infectious Disease Rapid Diagnostic Testing Market By Diseases Insights & Trends Revenue (USD Million)

Request customization of the report @

Thank you for reading our report. Customization of this report is available as per the client’s requirements. Please connect with us to know more about the report, and our team will ensure you get the report tailored according to your needs. 

Media Contact
Company Name: Emergen Research
Contact Person: Eric Lee
Email: Send Email
Phone: +1 (604) 757-9756
Address:14671 110 Avenue Surrey, British Columbia, V3R2A9
City: Surrey
State: British Columbia
Country: Canada